Close Menu

NEW YORK – Shares of Fulgent Genetics were up nearly 16 percent in Thursday morning trading, following an announcement that the firm had landed a contract to perform coronavirus testing for New York City's schools.

On Wednesday afternoon, Fulgent, based in Temple City, California, announced it has partnered with New York City Health and Hospitals, a public benefit corporation that operates the city's municipal healthcare system, to provide back-to-school COVID-19 testing.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.